News Network

Multiple sclerosis experts discuss data from four presentations on ozanimod, a disease modifying therapy that was presented at EAN 2022.

Key opinion leaders and presenters offer their insight on the latest advances in the management of patients with multiple sclerosis at the 2022 Consortium of Multiple Sclerosis Centers annual meeting.

Key opinion leaders and presenters at the 2022 American Academy of Neurology annual meeting share their perspectives on the latest advances in the management of patients with multiple sclerosis.

Key opinion leaders and presenters at the ACTRIMS Forum 2022 share their perspectives on the latest data and updates in the management of patients with multiple sclerosis (MS).

Leading physicians in the treatment of multiple sclerosis (MS) offer insights into presentations and data readouts from the 2021 Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting.

Experts in the treatment of multiple sclerosis (MS) offer insights into data presented at the 2021 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress.

Trevor J. Resnick, MD, and Amit Verma, MD, review data presented at the American Epilepsy Society (AES) Annual Meeting 2020.

Experts in multiple sclerosis review top data presented at the 8th joint ACTRIMS-ECTRIMS meeting.